Lilley's Pharmacology for Canadian Health Care Practice 5th Edition – 2024, Authors: Kara
1
Sealock| Cydnee Seneviratne Test Bank
Test Bank Complete_
Lilley’s Pharmacology For Canadian Health Care Practice 5th Edition-2024,
Authors: Kara Sealock| Cydnee Seneviratne (Part 1-10| All chapters 1-58)
5TH EDITION
, Lilley's Pharmacology for Canadian Health Care Practice 5th Edition – 2024, Authors: Kara
2
Sealock| Cydnee Seneviratne Test Bank
TABLE OF CONTENTS
PART 1. PHARMACOLOGY BASICS ______________________________________________ 5
Chapter 01: Nursing Practice In Canada And Drug Therapy ______________________________ 5
Chapter 02: Pharmacological Principles ____________________________________________ 17
Chapter 03: Legal And Ethical Considerations ________________________________________ 24
Chapter 04: Patient-Focused Considerations ________________________________________ 31
Chapter 05: Gene Therapy And Pharmacogenomics __________________________________ 43
Chapter 06: Medication Errors: Preventing And Responding ____________________________ 46
Chapter 07: Patient Education And Drug Therapy ____________________________________ 50
Chapter 08: Over-The-Counter Drugs And Natural Health Products ______________________ 57
Chapter 09: Vitamins And Minerals ________________________________________________ 64
Chapter 10: Principles Of Drug Administration _______________________________________ 71
PART 2. DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM _______________________ 85
Chapter 11: Analgesic Drugs _____________________________________________________ 85
Chapter 12: General And Local Anaesthetics ________________________________________ 94
Chapter 13: Central Nervous System Depressants And Muscle Relaxants ______________ 101
Chapter 14: Central Nervous System Stimulants And Related Drugs ____________________ 108
Chapter 15: Antiepileptic Drugs __________________________________________________ 115
Chapter 16: Antiparkinsonian Drugs ______________________________________________ 123
Chapter 17: Psychotherapeutic Drugs _____________________________________________ 130
Chapter 18: Substance Misuse ___________________________________________________ 140
PART 3. DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM___________________ 151
Chapter 19: Adrenergic Drugs ___________________________________________________ 151
Chapter 20: Adrenergic-Blocking Drugs____________________________________________ 159
Chapter 21: Cholinergic Drugs ___________________________________________________ 166
Chapter 22: Cholinergic-Blocking Drugs ___________________________________________ 173
PART 4. DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEM ____________ 180
Chapter 23: Antihypertensive Drugs ______________________________________________ 180
Chapter 24: Antianginal Drugs ___________________________________________________ 187
Chapter 25: Heart Failure Drugs _________________________________________________ 196
Chapter 26: Antidysrhythmic Drugs ______________________________________________ 204
Chapter 27: Coagulation Modifier Drugs ___________________________________________ 211
, Lilley's Pharmacology for Canadian Health Care Practice 5th Edition – 2024, Authors: Kara
3
Sealock| Cydnee Seneviratne Test Bank
Chapter 28: Antilipemic Drugs ___________________________________________________ 218
Chapter 29: Diuretic Drugs ______________________________________________________ 227
Chapter 30: Fluids And Electrolytes _______________________________________________ 234
PART 5. DRUGS AFFECTING THE ENDOCRINE SYSTEM ____________________________ 241
Chapter 31: Pituitary Drugs _____________________________________________________ 241
Chapter 32: Thyroid And Antithyroid Drugs ________________________________________ 247
Chapter 33: Antidiabetic Drugs __________________________________________________ 255
Chapter 34: Adrenal Drugs ______________________________________________________ 265
Chapter 35: Women’s Health Drugs ______________________________________________ 271
Chapter 36: Men’s Health Drugs _________________________________________________ 281
PART 6. DRUGS AFFECTING THE RESPIRATORY SYSTEM __________________________ 288
Chapter 37: Antihistamines, Decongestants, Antitussives, And Expectorants _____________ 288
Chapter 38: Respiratory Drugs ___________________________________________________ 295
PART 7. DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM AND NUTRITION _______ 302
Chapter 39: Acid-Controlling Drugs _______________________________________________ 302
Chapter 40: Antidiarrheal Drugs And Laxatives _____________________________________ 309
Chapter 41: Antiemetic And Antinausea Drugs _____________________________________ 317
Chapter 42: Nutritional Supplements _____________________________________________ 323
PART 8. ANTI-INFECTIVE AND ANTI-INFLAMMATORY DRUGS ______________________ 329
Chapter 43: Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, And
Tetracyclines _________________________________________________________________ 329
Chapter 44: Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, And Other Drugs ______ 336
Chapter 45: Antiviral Drugs _____________________________________________________ 342
Chapter 46: Antitubercular Drugs ________________________________________________ 350
Chapter 47: Antifungal Drugs____________________________________________________ 357
Chapter 48: Antimalarial, Antiprotozoal, And Anthelmintic Drugs ______________________ 366
Chapter 49: Anti-Inflammatory And Antigout Drugs _________________________________ 372
PART 9. IMMUNE AND BIOLOGICAL MODIFIERS AND CHEMOTHERAPEUTIC DRUGS ____ 379
Chapter 50: Immunosuppressant Drugs ___________________________________________ 379
Chapter 51: Immunizing Drugs And Pandemic Preparedness __________________________ 385
Chapter 52: Antineoplastic Drugs Part 1: Cancer Overview And Cell Cycle–Specific Drugs ___ 391
Chapter 53: Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific And Miscellaneous Drugs __ 398
Chapter 54: Biological Response–Modifying Drugs And Antirheumatic Drugs _____________ 402
, Lilley's Pharmacology for Canadian Health Care Practice 5th Edition – 2024, Authors: Kara
4
Sealock| Cydnee Seneviratne Test Bank
PART 10. MISCELLANEOUS THERAPEUTICS: HEMATOLOGICAL, OPHTHALMIC, AND OTIC
DRUGS __________________________________________________________________ 408
Chapter 55: Anemia Drugs ______________________________________________________ 408
Chapter 56: Dermatological Drugs________________________________________________ 415
Chapter 57: Ophthalmic Drugs___________________________________________________ 422
Chapter 58: Otic Drugs _________________________________________________________ 428
, Lilley's Pharmacology for Canadian Health Care Practice 5th Edition – 2024, Authors: Kara
5
Sealock| Cydnee Seneviratne Test Bank
PART 1. PHARMACOLOGY BASICS
Chapter 01: Nursing Practice In Canada And Drug Therapy
Lilley's Pharmacology for Canadian Health Care Practice 5th Edition – 2024,
Authors: Kara Sealock| Cydnee Seneviratne Test Bank
MULTIPLE CHOICE
1. When Assessing A Patient’s Readiness For Medication Therapy, Which Factor Is
The Most Critical For The Nurse To Evaluate?
A. The Patient's Literacy Level
B. The Patient's Insurance Status
C. The Patient's Previous Experiences With Medications
D. The Patient's Family Dynamics
ANS: C
Understanding A Patient’s Previous Experiences With Medications Can Greatly
Influence Their Readiness And Compliance With The New Therapy. Literacy Levels,
Insurance Status, And Family Dynamics Are Important But Do Not Directly Impact
The Patient's Immediate Ability To Engage With The Treatment Plan.
DIF: Cognitive Level: Comprehension
2. When The Nurse Is Considering The Timing Of A Drug Dose, Which Is Most
Important To Assess?
A. The Patient’s Identification
B. The Patient’s Weight
C. The Patient’s Last Meal
D. Any Drug Or Food Allergies
ANS: C
, Lilley's Pharmacology for Canadian Health Care Practice 5th Edition – 2024, Authors: Kara
6
Sealock| Cydnee Seneviratne Test Bank
The Pharmacokinetic And Pharmacodynamic Properties Of The Drug Need To Be
Assessed With Regard To Any Drug–Food Interactions Or Compatibility Issues. The
Patient’s Identification, Weight, And Drug Or Food Allergies Are Not Affected By
The Drug’s Timing.
DIF: Cognitive Level: Comprehension
3. Which Of The Following Strategies Is Essential For Promoting Patient Adherence
To Medication Regimens?
A. Providing Written Materials Only
B. Involving Family Members In The Education Process
C. Focusing Solely On The Medication’s Side Effects
D. Using Medical Jargon To Explain Therapy
ANS: B
Involving Family Members Can Provide Additional Support And Reinforce The
Patient’s Understanding Of The Medication Regimen, Thereby Promoting Adherence.
Providing Written Materials Alone Or Using Jargon Can Lead To Misunderstanding,
While Focusing Only On Side Effects Does Not Address Overall Medication
Management.
DIF: Cognitive Level: Comprehension
4. Which Constitutes The Traditional Five Rights Of Medication Administration?
A. Right Drug, Right Route, Right Dose, Right Time, And Right Patient
B. Right Drug, The Right Effect, The Right Route, The Right Time, And The Right
Patient
C. Right Patient, Right Strength, Right Diagnosis, Right Drug, And Right Route
D. Right Patient, Right Diagnosis, Right Drug, Right Route, And Right Time
